Harvard Bioscience (HBIO) Prepaid Assets (2010 - 2026)

Harvard Bioscience (HBIO) has reported Prepaid Assets for 17 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 17.74% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (up 17.74% YoY), while the FY2025 annual figure was $2.8 million, down 4.66% from the prior year.
• Prepaid Assets improved to $3.6 million in Q1 2026 per HBIO's latest filing, from $2.8 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $5.5 million in Q3 2022 and bottomed at $2.8 million in Q4 2025.
• Historically, Prepaid Assets has averaged $4.0 million across 5 years, with a median of $3.9 million in 2023.
• Annual changes were most pronounced in 2022 — Prepaid Assets surged 37.51% — and 2025, when it plunged 31.18%.
• Harvard Bioscience's Prepaid Assets stood at $3.5 million in 2022, then grew by 13.48% to $3.9 million in 2023, then dropped by 26.45% to $2.9 million in 2024, then declined by 4.66% to $2.8 million in 2025, then surged by 30.44% to $3.6 million in 2026.
• Business Quant data shows HBIO's Prepaid Assets at $3.6 million in Q1 2026, $2.8 million in Q4 2025, and $3.3 million in Q3 2025.